Table 6.
4NQO induced combined with GEMMs for OSCC.
4NQO application and treatment period (/weeks) | Mouse strains | Conclusions | Ref. |
---|---|---|---|
50 μg/mL 4NQO in drinking water for 16 or 30 weeks | Ndrg2-deficient mice (Ndrg2+/− and Ndrg2−/− mice) | Tumors in Ndrg2-deficient mice were significantly developed faster and larger. | (82) |
100 μg/mL 4NQO in drinking water for 8 weeks | Heterozygous p53 knockout mice (p53+/−) | Anti-PD-1 can prevent OSCC development and progression. | (89) |
150 μg/mL 4NQO in drinking water for 18 weeks | Nlrp3−/− and Caspase1−/− mice | NLRP3 inflammasome promoted 5-FU resistance of OSCC in vivo. | (141) |
100 μg/mL 4NQO in drinking water for 16 weeks | K14-EGFP-miR-211 transgenic mice tagged with GFP | MicroRNA-211 enhances the oncogenicity of carcinogen-induced oral carcinoma by repressing TCF12 and increasing antioxidant activity. | (199) |
100 μg/mL 4NQO in drinking water for 16 weeks | K14-EGFP-miR-31 transgenic mice tagged with GFP | The transgenic mice had a higher susceptibility for 4NQO-induced oral and esophagus tumorigenesis. | (200) |
50 or 200 μg/mL in drinking water for 28 weeks | CCL3−/− mice; CCR5−/− mice; CCR1−/− mice | SCC tumor formation is reduced in CCL3 and CCR5 deficient mice. | (201) |
100 μg/mL 4NQO in drinking water for 16 weeks | Gal3−/− male mice | In Gal3+/+ mice, the Hh signaling pathway might play an essential role in tongue carcinoma development. | (202) |
50 or 200 μg/mL 4NQO in drinking water for 28 weeks | ACKR2−/− mice | No differences in the SCC incidence comparing wide-type and ACKR2−/− treated mice. | (203) |